Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine

Erstveröffentlichung
2022Authors
Döhner, Hartmut
Wei, Andrew H.
Roboz, Gail J.
Montesinos, Pau
Thol, Felicitas R.
Wissenschaftlicher Artikel
Published in
Blood ; 140 (2022), 15. - S. 1674-1685. - ISSN 0006-4971. - eISSN 1528-0020
Link to publication
https://dx.doi.org/10.1182/blood.2022016293Institutions
UKU. Klinik für Innere Medizin IIISubject headings
[Free subject headings]: MINIMAL RESIDUAL DISEASE | ACUTE MYELOID-LEUKEMIA | MULTIPARAMETER FLOW-CYTOMETRY | ACUTE MYELOGENOUS LEUKEMIA | WORLD-HEALTH-ORGANIZATION | UNSELECTED PATIENTS | OLDER PATIENTS | CLASSIFICATION | RELEVANCE | RELAPSE[DDC subject group]: DDC 610 / Medicine & health